Next Article in Journal
Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year
Previous Article in Journal
The Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) Improves Diagnostic Efficacy in Predicting the Prognosis of Epithelial Ovarian Cancer Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis

1
School of Medical and Health Sciences, Tung Wah College, 31 Wylie Road, HoManTin, Hong Kong
2
Department of Biological and Biomedical Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, UK
3
Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
*
Authors to whom correspondence should be addressed.
Cancers 2023, 15(20), 5063; https://doi.org/10.3390/cancers15205063
Submission received: 17 September 2023 / Revised: 9 October 2023 / Accepted: 14 October 2023 / Published: 19 October 2023
(This article belongs to the Section Cancer Causes, Screening and Diagnosis)

Abstract

:

Simple Summary

Glioblastoma (GBM) is one of the most common malignant primary brain tumors. The gold standard of cancer diagnosis relies on a medical technologist and a pathologist for feature-based analysis of hematoxylin and eosin-stained slides. To improve the efficiency of GBM diagnosis, an artificial intelligence model was built based on the TCGA-GBM dataset, and was deployed on an independent dataset collected locally. The support vector machine model showed excellent accuracy with very good sensitivity and specificity. It could potentially be used for GBM diagnosis and future clinical application.

Abstract

Background: Glioblastoma (GBM) is one of the most common malignant primary brain tumors, which accounts for 60–70% of all gliomas. Conventional diagnosis and the decision of post-operation treatment plan for glioblastoma is mainly based on the feature-based qualitative analysis of hematoxylin and eosin-stained (H&E) histopathological slides by both an experienced medical technologist and a pathologist. The recent development of digital whole slide scanners makes AI-based histopathological image analysis feasible and helps to diagnose cancer by accurately counting cell types and/or quantitative analysis. However, the technology available for digital slide image analysis is still very limited. This study aimed to build an image feature-based computer model using histopathology whole slide images to differentiate patients with glioblastoma (GBM) from healthy control (HC). Method: Two independent cohorts of patients were used. The first cohort was composed of 262 GBM patients of the Cancer Genome Atlas Glioblastoma Multiform Collection (TCGA-GBM) dataset from the cancer imaging archive (TCIA) database. The second cohort was composed of 60 GBM patients collected from a local hospital. Also, a group of 60 participants with no known brain disease were collected. All the H&E slides were collected. Thirty-three image features (22 GLCM and 11 GLRLM) were retrieved from the tumor volume delineated by medical technologist on H&E slides. Five machine-learning algorithms including decision-tree (DT), extreme-boost (EB), support vector machine (SVM), random forest (RF), and linear model (LM) were used to build five models using the image features extracted from the first cohort of patients. Models built were deployed using the selected key image features for GBM diagnosis from the second cohort (local patients) as model testing, to identify and verify key image features for GBM diagnosis. Results: All five machine learning algorithms demonstrated excellent performance in GBM diagnosis and achieved an overall accuracy of 100% in the training and validation stage. A total of 12 GLCM and 3 GLRLM image features were identified and they showed a significant difference between the normal and the GBM image. However, only the SVM model maintained its excellent performance in the deployment of the models using the independent local cohort, with an accuracy of 93.5%, sensitivity of 86.95%, and specificity of 99.73%. Conclusion: In this study, we have identified 12 GLCM and 3 GLRLM image features which can aid the GBM diagnosis. Among the five models built, the SVM model proposed in this study demonstrated excellent accuracy with very good sensitivity and specificity. It could potentially be used for GBM diagnosis and future clinical application.

1. Introduction

Glioblastoma (GBM) is one of the most common malignant primary brain tumors, which accounts for 60–70% of all gliomas [1], and is classified as a grade IV tumor by the World Health Organization (WHO) based on histopathological features. Its invasiveness and high vascularity properties promote its spread throughout the brain parenchyma, resulting in a high frequency of recurrence and poor prognosis [2]. Early diagnosis and effective treatment planning is crucial in improving the survival rate of patients.

1.1. Morphology-Based Analysis

Compared to radiological imaging, which shows the location and the size of the tumor, histopathological images provide a more important basis for cancer diagnosis. Our previous studies illustrated that accurate identification of a tumor is crucial for treatment planning [3,4]. The gold standard of glioblastoma diagnosis and post-operation treatment planning is based on the identification of tumor cells on histopathological slides by both experienced medical technologists and pathologists. Morphological study of the cancer cells, including the shape, size, and structure of the components (first order statistics) within the cell and the cellular arrangement within the tissue will be investigated and compared to the normal cells and tissues. In view of cancer cells, they are characterized by their irregular size and shape, with a large nucleus, and with prominent nucleoli [5]. However, manual diagnosis of histopathological images requires pathologists who have been trained for years. Moreover, the diagnosis process is time consuming and labor intensive [6]. The development of AI-based histopathological image analysis further improves cancer diagnosis via accurate counting of cell types and/or quantitative analysis. However, due to the tumor heterogeneity, the accuracy of using the computer-assisted histopathological image analysis for GBM diagnosis still requires improvement [7].

1.2. Texture-Based Analysis

Recently, the advancement of digital pathology enables high-resolution histopathological image analysis, which allows researchers to access more features from computer-aided digital image analysis. It allows the presentation of detailed quantitative histo-morphometry features, including histologic primitives (e.g., glands and nuclei) from a standard hematoxylin and eosin (H&E) slide in the whole slide image [8]. A recent study applied the contouring of different cells from prostate cancer histopathology images to reduce the screening time for diagnosis and improve the diagnostic accuracy [9]. The high-resolution histopathological images also enable us to perform texture-based features analysis at pixel level, which could be a game-changer for cancer diagnosis. Gray level co-occurrence matrix (GLCM) and gray level run length matrix (GLRLM) are two categories of texture-based analysis methods. GLCM is the statistics of pixel intensity distribution. It considers the statistics of pairs of pixels in certain spatial relations to each other and provides information on the classification of textures [10]. GLRLM quantifies gray level runs, that is the length in number of pixels, with the same gray level value consecutively [11]. Both GLCM and GLRLM give a more comprehensive analysis of the histopathological image when compared to the traditional first order statistical analysis. Previous studies employed GLCM and GLRLM image features, mainly in radiological images for cancer screening [12], cancer diagnosis [13,14], prognosis prediction [15,16], and for disease types classification in dementia [17].

1.3. Machine Learning in Cancer Diagnosis

To handle a large number of image features in one pass effectively, machine learning is valued in analysis and diagnosis for medical images with minimal human intervention. The applications of machine learning include in medical imaging for organ segmentation [18,19], and co-registration of medical images from multiple modalities [20], so as to improve the accuracy in organs segmentation in CT images, and co-registration in multiple imaging modalities for accurate tumor localization. Furthermore, artificial intelligence algorithms can analyze medical images simultaneously with remarkable speed. It not only improves accuracy in handling large amount of medical and imaging data, but also significantly reduces the time required for diagnosis. Hence, computer-aided diagnosis in cancer using CT or MRI images has been proposed for lung cancer [21] and head and neck cancer diagnosis [22].
However, the application of machine learning in previous studies mainly focuses on radiological images. Recent studies applied machine learning to histopathological images analysis including breast cancer classification [23,24,25] and cervical cancer detection [26].
Therefore, in this study, we aimed to develop an AI system to aid pathologists in GBM diagnosis via texture-based image analysis. We employed texture-based analysis on the image features of histopathological slides, to identify the image features and their correlation to those features that pathologists used for the traditional diagnosis of GBM. Moreover, we further verified the AI system with local clinical data for future application.

2. Materials and Methods

2.1. Patient Dataset

There were two datasets involved in this study, The first dataset was the Cancer Genome Atlas Glioblastoma Multiforme Collection (TCGA-GBM), which was retrieved from The Cancer Imaging Archive (TCIA) [27]. There are 262 participants in this dataset, which come from eight oncology centers. This dataset comprises tissue slide images, CT images, MR images in DICOM format, as well as clinical data [28]. Clinical data, including the age at diagnosis, sex, tumor histology, overall staging, and survival days after confirmed diagnosis were also collected. The disease was staged by the 2007 World Health Organization (WHO) classification of tumors of the central nervous system [29].
The second dataset comprised hematoxylin and eosin (H&E) slide images collected from a local hospital in Hong Kong. Ethics approval was obtained from the IRB and was compliant with the guidance of Declaration of Helsinki, and the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, Guideline for Good Clinical practice (ICH GCP) in order to safeguard the rights, safety, and well-being of research subjects. It comprised a group of 60 patients diagnosed with GBM during 2018–2020, and another group of 60 participants with no known brain diseases as normal control. Brain tissue samples and tumor samples were collected in the department of pathology. The tissue blocks were retrieved and staining was performed. H&E slides were reproduced for each patient. Patient demographics including age, sex, and tumor histology were recorded.

2.2. Digitize Image from H&E Tissue Slide and Pre-Processing of Images

2.2.1. Digitize the H&E Tissue Slide from TCGA-GBM

The original TCGA-GBM dataset was composed of 510 hematoxylin and eosin (H&E) stained histological slides from 262 patients in .svs format. The software Aperio ImageScope version. 12.4.3.5008 was used to view the .svs files. Within the software, the 10× objective was chosen with a total magnification of 100× used to capture the slides one by one with no overlap. The images were saved as .tif format, with 1304 × 839 pixel.

2.2.2. Digitize the H&E Tissue Slide from Local Hospital

The hematoxylin and eosin (H&E)-stained histological slides from GBM patients were placed onto the stage of a light microscope (Zeiss Primostar 3 microscope, Carl Zeiss Microscope GmbH, Jena, Germany). The tissue slide was focused under 10× objective (Zeiss iPlan-Achromat 10× lens) with a total magnification of 100×. Images of pixel 1304 x 839 (same as the image size of TCGA-GBM) were captured one by one with no overlap using the high-resolution CCD camera. (The microscope was equipped with the integrated 4K microscope camera, with Sony CMOS image color sensor, maximum pixel count 3840 (H) × 2160 (W) = 8.3-megapixel HD (4K) and the imaging software (Labscope v2.9). The image was saved as .tif format for further processing.

2.2.3. Standardization and Normalization of Images

A trained medical technologist contoured the regions of interest (ROIs). The ROI of the diseased group is where the cancer cells are located, while the ROI of the control group is where normal brain cells are located. A pathologist checked and confirmed the ROI was accurately contoured. Images were taken within the ROI only.
Color staining and white balance normalization were performed for all images collected to ensure the image features collected were standardized. The pre-processing procedures were done to minimize the variation among images collected from various hospitals. The captured images were analyzed for further image feature analysis. The workflow of the digitized image and pre-processing image are presented in Figure 1. Details of the study dataset are presented in Table 1.

2.3. Image Feature Extraction from Tissue Slide Images

Twenty-two gray level co-occurrence matrix (GLCM) image features and eleven gray level run length matrix (GLRLM) image features were extracted from the H&E slide images. Image feature extraction was performed by an in-house developed program, built based on the image processing toolbox of MATLAB® (The MathWorks Inc., Natick, Massachusetts, United States) 2021a platform. The definition of 22 GLCM and 11 GLRLM image features are listed in Table 2. The mathematical formula to calculate each feature from the digital image were listed in the File S1.

2.4. Study Workflow

The study comprised two parts. Part 1 aimed to build the models for GBM diagnosis using five commonly used machine learning algorithms. In this part, the images from the TCGA-GBM dataset and images from the normal cohort collected from the local hospital were used. A balanced sample was used to build the model, i.e., the number of images was similar in both the GBM and normal group. This was to ensure the model trained was not biased towards one group. In other words, the model did not favor any of the group due to it containing more data [36].
After image pre-processing, all images (from both the GBM and the normal) were randomly split into three independent groups, with 70% for the training group, 15% for the validation group, and 15% for the testing group. Details are shown in Table 3. The images were sent to the in-house developed software for 22 GLCM and 11 GLRLM image features extraction, and then to the classification learner application in Matlab 2021a for model building. The decision tree (DT) algorithm, the extreme boost (EB) algorithm, the random forest (RF) algorithm, the support vector machine (SVM) algorithm, and the linear model algorithm (LM) were employed for model building. Each model was trained, tested, and validated. As a result, five models were built, including DT model, EB model, SVM model, RF model, and LM model.
In part 2, independent histopathological images from the local hospital were used for model deployment. The 702 images from local GBM patients and 670 images from the local normal cohort (which were independent from those in the normal cohort for part 1) were used. After image pre-processing, images were sent to the in-house developed software for 22 GLCM and 11 GLRLM image features extraction. This time, the image features were sent to the five models built in part 1 to verify whether the model was able to diagnose GBM from normal. A confusion matrix, ROC analysis, and ROC comparison were conducted to identify the best model for GBM diagnosis. Figure 2 is an illustration diagram of the study workflow.

2.5. Machine Learning Algorithms

Five machine-learning algorithms in the classification learner application of Matlab 2021a were employed. They were the decision tree (DT) algorithm, the extreme boost (EB) algorithm, the random forest (RF) algorithm, the support vector machine (SVM) algorithm, and the linear model (LM). These are common machine learning algorithms, which facilitate the comparison of our results with other studies.
For each learning algorithm, the 22 GLCM and 11 GLRLM image features were used. The diagnostic outcome was presented as a binary output, i.e., decimal value ranging between 0 and 1 (with 0 and 1 inclusive). A decimal value of less than 0.5 indicated the model predicting the patient was normal, whereas a decimal value equal to or greater than 0.5 indicated the model predicting the patient suffered from GBM.

2.6. Ten-Fold Cross Validation to Minimize Overfitting

To minimize the overfitting and improve the generalization capability of the developed system, a 10-fold cross validation was employed. The dataset was randomly divided into ten groups with an equal number of samples. The first training used the initial nine groups as training data, and the remaining group as testing data. The second training continued with another nine groups as training data and the rest as testing data. The process continued 10 times. The performance of the model was the average of the result computed in these 10 training iterations [37].

2.7. Data Analysis

The performance of the 5 machine-learning algorithms were assessed by the overall accuracy, sensitivity, and specificity, as well as the area under the receiver operating characteristic (ROC) curve. Also, a bivariate Chi-square test was performed to calculate the statistical significance of the difference between the ROC curves estimates, using the ROCKIT ver1.1B2 software, developed by the University of Chicago.

2.8. Deployment of Models—Verified by Local Data

The models built in Section 2.4 were deployed. The local dataset was used to test the performance of the deployed models. The performance of the five models built in part 1 was assessed by the overall accuracy, sensitivity, and specificity, as well as the area under the receiver operating characteristic (ROC) curve. A bivariate Chi-square test was performed to calculate the statistical significance of the difference between the ROC curves estimates, using the ROCKIT ver1.1B2 software, developed by the University of Chicago.

3. Results

3.1. Dataset Demographics

The TCGA GBM dataset and the local hospital dataset comprise 262 and 60 patients, respectively. The demographics of the study cohorts are shown in Table 4. A sample set of the H&E histology of normal brain tissue and GBM with histological characteristics is shown in Figure 3.

3.2. Image Features Selection

Among the 22 GLCM and 11 GLRLM image features, 15 features separate normal and GBM well. In GLCM, there are 12 image features including contrast (contr), difference variance, dissimilarity (dissi), energy (Energ), entropy (Entro), homogeneity 1 (Homom), homogeneity 2 (homop), maximum probability, sum average, sum entropy, difference entropy, information measure of correlation 1, inverse difference normalized, and inverse difference moment normalized. In GLRLM, there are three image features including gray level non-uniformity, low gray level fun emphasis, and long run low gray level emphasis. Details of each feature are listed in Table 5.

3.2.1. GLCM Image Features

Autocorrelation is a measure of the texture magnitude related to fineness and coarseness. The smaller the number, the finer the image. Moreover, the smaller range of autocorrelation indicated that the image composes of finer details. Our results showed that the range for the normal group was 15–31, while the range for the GBM group was 10.5–57. To present the image features with standardized autocorrelation, all other image features were illustrated versus autocorrelation in Figure 4, Figure 5, Figure 6, Figure 7 and Figure 8.

Image Features Related to Local Intensity Variation

Contrast and difference variance are image features that are related to local intensity variation. Contrast in GLCM indicated the intensity variation between adjacent pixels, where a high degree of contrast meant the intensity varied rapidly. The contrast was low for the normal group (blue), which was below 0.4. The contrast ranged from 0.5 to 3.5 for the GBM group. There was a similar situation for difference variance. The details are listed in Figure 4.

Image Features Related to Entropy

Entropy specifies the randomness in the image, where the higher value indicates that the image is more complex with higher randomness [33]. Our results showed that the entropy, sum entropy, and difference entropy were below 1.52, 1.3, and 0.6 for the normal group, and above 1.6, 1.5, and 0.8 for the GBM group, respectively. Details are listed in Figure 5.

Image Features Related to Dissimilarity

Dissimilarity measures the relationship between the occurrences of pairs with differing intensity values and that of the similar intensity values. The dissimilarity in the normal group was below 0.3 whereas it was higher than 0.3 in the GBM group. The higher the dissimilarity, the higher the difference in average of the image value. Details are listed in Figure 6.

Image Features Related to Energy and Maximum Probability

Energy measures the amount of variation within a fixed size window by using local masks. The level, edge, spot, and ripple can be segmented within the image [38]. The energy in the normal group was higher than 0.28 whereas it was lower than 0.28 in the GBM group. A higher energy indicates more instances of intensity value pairs that were next to its neighbor at higher frequencies. Similarly, maximum probability measured the occurrences of the most predominant pair of neighboring intensity value. Our results showed that it was lower than 0.43 in the GBM group whereas it was higher than 0.5 in the normal group. Details are listed in Figure 7.

Image Features Related to Homogeneity

Homogeneity 1, also known as inverse difference, is a measure of the uniformity of intensity values of pixel pairs [35]. The higher the value, the more uniform the image intensity. The homogeneity 1 for the normal group was higher than 0.85, while it was lower than 0.85 for the GBM group. Homogeneity 2, also known as inverse difference moment, is a measure of local homogeneity within the image. The weighting is the inverse of the contrast weighting in GLCM. Our results showed that the homogeneity 2 for the normal group was higher than 0.85, while it was lower than 0.85 for the GBM group.
The inverse difference normalized (IDN) and the inverse difference moment normalized (IDMN) are the normalized version of homogeneity 1 and homogeneity 2, respectively. IDN normalized the difference of intensity values between the neighboring pixels by dividing over the total number of discrete intensity values. Our results showed that it was higher than 0.97 and lower than 0.97 for the normal group and GBM group, respectively. For IDMN, it normalizes the square of the difference of intensity values between neighboring pixels by dividing over the square of the total number of discrete intensity values. The cutoff value is 0.995. The GBM group was lower than the cutoff value, while the normal group was higher than the cutoff value. Details are listed in Figure 8.

3.2.2. GLRLM Image Features

GLRLM was first introduced by Galloway et al., 1975 [11]; it assesses the length of a consecutive sequence of pixels with the same grey level. Gray level non-uniformity (GLN) measures the similarity of gray level intensity in the image. The lower the GLN, the more similar the intensity values. Our results showed that within the normal group, the majority of GLN values were lower than 1 × 105, while they were higher than 1 × 105 for the GBM group.
Low gray level run emphasis measures the low gray-level values distribution, a higher value indicating more low gray-level values in the image. Our results showed that LGRE was under 0.3 in the normal group, while it was higher than 0.49 for the GBM group. It indicated that the GBM group image showed a greater concentration of low gray level values in the image.
Long run low gray-level emphasis (LRLGE) measures the joint distribution of long run lengths with lower gray-level values. The higher value indicates a longer consecutive sequence of low gray-level values in the image. Our results showed that LRLGE was under 5.1 in the normal group, while it is ranged from 5.2 to 35 for the GBM group. Details are listed in Figure 9.

3.3. Model Building and Validation Using Images from TCGA-GBM

The GLCM and GLRLM image features were extracted from 1500 images from TGBA-GBM patients and 1500 images from normal patients; all five models created achieved excellence performance with 100% accuracy, with 100% sensitivity and specificity. The same results were attained from a 10-fold cross validation. There was no significant difference in the accuracy among the five algorithms of the ROC curves (p > 0.05) in the Chi-square test. Detailed results, the ROC curves, and the confusion matrix are shown in Table 5 and Figure 10, respectively.

3.4. Model Deployment Using Images from Local Hospital

Among the five models, the SVM model showed the highest overall accuracy of 93.5%, with the highest sensitivity of 86.95% and specificity of 99.73%. The other four models showed unsatisfactory results in GBM diagnosis, with 55.0–60.3% accuracy. The main issue was poor performance in sensitivity, with 0% to 20.8% only. Furthermore, the accuracy of the SVM model was statistically significantly better than the other models, with p < 0.05 in the Chi-square test. Detailed results, the ROC curves, and the confusion matrix are shown in Table 6 and Figure 11, respectively.

4. Discussion

4.1. Significance of This Project

In this study, we identified 12 GLCM and 3 GLRLM image features from 22 GLCM and 11 GLRLM image features extracted which can aid in the diagnosis of GBM. Among the five models built, the SVM model proposed in this study demonstrated excellent accuracy with very good sensitivity and specificity. It could potentially be used for GBM diagnosis and future clinical application.

4.2. The Value of GLCM and GLRLM Image Features in H&E Images

Traditionally, GBM diagnosis mainly focuses on the identification of cancer features from H& E slides, including cellular morphology, multiple nucleoli, and irregular shape of nucleus, i.e., a morphology-based analysis [39]. Accurate diagnosis required pathologists’ years of diagnostic experience, as well as their concentration. The diagnostic process is labor intensive and time consuming. The reproducibility of manual diagnosis is low and subject to inter-observer agreement. The machine-assisted (AI based) morphological analysis may partially overcome these shortcomings. However, due to the high degree of tumor heterogeneity in GBM, large scale morphological analysis remains challenging [7].
In this study, we proposed to use the GLCM and GLRLM, where they are based on the statistical study of pixel intensity distribution of the image [10] for GBM diagnosis. GLCM represents the frequency of a pixel with gray level i present in a spatial location to a gray level j, in 3 directions, including vertical, horizontal, or diagonal [40]. In an oncology diagnostic setting, the targeted lesions usually present with multiple nucleoli and irregular sizes and shapes. It is expected that the gray-level pixel intensity variation is higher, with higher randomness, higher variation in the gray-level of neighboring pixels, and less homogeneity in GBM compared to normal cells, as the GLCM of lesion and the normal are different in nature [41]. From the first part of this study, we identified 12 GLCM that are significantly different between GBM and the normal group. The GLCM features match the characteristics of GBM histopathological images. Within GLCM, the GBM group was high in contrast and difference variance, indicating that the gray-level intensity variation was higher in the GBM group when compared to the normal group. For image feature-related to entropy, GBM showed a higher value which indicates that it is more complex with higher randomness when compared to the normal group. In view of image features related to dissimilarity, which measure the occurrence of pairs of pixels with differ intensity, the GBM group showed a higher difference in average the image value. For the image feature related to energy, which showed the amount of variation within the image, the GBM group showed a lower value in energy and maximum probability, indicating the image is higher in variation in the gray-level of neighbor pixels when compared to the normal. For homogeneity, the GBM group showed lower values, which indicates that it is less homogeneous in gray-level when compared to the normal group.
In addition, we identified three GLRLM features that are suitable for GBM diagnosis. GLRLM represents the gray-level runs, that is, the length in number of consecutive pixels that have the same gray-level value [11]. Most GBMs exhibit nuclear atypia, multiple mitotic figures, and a high degree of nuclear pleomorphism. Within the tumor, central necrosis is a signature of GBM, which are in yellow in histopathological images, with a peripheral grayish tumor mass [42]. The characteristic features match with our results, where the GBM group showed higher GLN values, which indicates less similarity in intensity value; a higher LGRE value indicating greater concentration of low gray-level value and a higher LRLGE value indicating a longer consecutive sequence of low gray-level value.

4.3. Advantage of SVM in Classification

SVM is a binary classifier, which used the hyperplane to define a clear decision boundary to separate various data points based on their classes [43]. In this study, SVM attained the best performance among the five most common machine-learning algorithms in the diagnostic model for GBM. SVM was first introduced by Vapnik as one of the classification algorithms focusing on solving inputs with a non-linear relationship [44]. Based on the results of current study, the accuracy of linear model was low, indicating that the relationship between the image features (GLCM and GLRLM) and the diagnosis were not linear. SVM maps the non-linear inputs into the newly generated space, where the inputs can be separated linearly [45]. In general, SVM has excellent generalization capability relative to other algorithms, especially in the case of fewer training samples. The major advantage of SVM is that it can classify data that are not linearly separable. Moreover, in our study, there were only 33 image features. This is particularly suitable for a multivariate algorithm, such as SVM, to simplify the data interpretation and prevent overfitting [46].

4.4. Study Limitations and Further Studies

In this study, an independent local cohort of GBM patients was used for model testing. The sample size was relatively small. Further study is suggested using another cohort of patients from different centers with a larger sample size to ensure the model is generalizable.
In future work, we will continue to investigate the multi-class characterization of brain tumors’ histopathological images. Further sub-class recognition may provide a comprehensive theoretical basis for medical technologists and pathologists for accurate diagnosis of brain tumors.

5. Conclusions

In this study, there were 12 GLCM and 3 GLRLM texture features identified which were suitable for GBM diagnosis. These features could be used for AI-based histopathological image analysis. Among the AI models developed, SVM offered the highest accuracy of 93.5% and attained 86.95% and 99.73% of sensitivity and specificity, respectively, demonstrating great potential for future clinical application.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cancers15205063/s1, File S1: GLCM & GLRLM equations.

Author Contributions

Conceptualization, E.Y.W.C.; methodology, E.Y.W.C. and A.S.M.L.; software, E.Y.W.C.; formal analysis, E.Y.W.C., A.S.M.L., and E.S.M.C.; investigation, E.Y.W.C., R.W.K.W., and E.S.M.C.; writing—original draft preparation, E.Y.W.C., R.W.K.W., and E.S.M.C.; writing—review and editing, E.Y.W.C., R.W.K.W., and E.S.M.C.; visualization, E.Y.W.C.; project administration, E.Y.W.C. and E.S.M.C.; funding acquisition, E.Y.W.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the College Research Grant of Tung Wah College, grant number 2020-00-51 CRG022005. The APC was funded by the College Research Grant and Staff Development Fund of Tung Wah College.

Institutional Review Board Statement

All patients formally consented through the participating institution during data collection for TCGA dataset. Ethics approval was granted by the Hong Kong East Cluster Research Ethics Committee (HKEC CREC) with reference number HKECREC-2022-053. Consent for publication was granted by the cancer imaging archive (TCIA).

Informed Consent Statement

Not applicable.

Data Availability Statement

Publicly available datasets were used in this study. The dataset can be obtained at following website: https://wiki.cancerimagingarchive.net/pages/viewpage.action?pageId=1966258 (accessed on 22 January 2023). Data used in preparation of this article were obtained from the Cancer Imaging Archive (TCIA) database (https://wiki.cancerimagingarchive.net/display/Public/Wiki) (accessed on 22 January 2023). The local dataset will be available upon request.

Acknowledgments

We would like to acknowledge the individuals and institutions that provided data for this collection: Pamela Youde Nethersole Eastern Hospital, Hong Kong—Special thanks to Yun Hoi Lui from the Department of Clinical Pathology; Henry Ford Hospital, Detroit, MI—Special thanks to Lisa Scarpace and Tom Mikkelsen, from the Department of Neurosurgery; Hermelin Brain Tumor Center. University of California, San Francisco, CA—Special thanks to Soonmee Cha, from the Department of Neurological Surgery, Brain Tumor Research Center; MD Anderson Cancer Center, Houston, TX—Special thanks to Sujaya Rao and Sangeeta Tekchandani from the Office of Translational/Clinical Research.; Emory University, Atlanta, GA—Special thanks to David Gutman, and Joel Saltz, from the Center for Comprehensive Informatics.; Thomas Jefferson University, Philadelpha, PA—Special thanks to Nancy Pedano and Adam E. Flanders, from the Department of Radiology, Jefferson Medical College.; CWRU School of Medicine, Cleveland, OH—Special thanks to Jill Barnholtz-Sloan, and Quinn Ostrom, MA, MPH from Case Comprehensive Cancer Center.; Duke University School of Medicine, Durham, NC—Special thanks to Daniel Barboriak, and Laura J Pierce.; Fondazione IRCCS Instituto Neuroligico C. Besta, Milan, Italy—Special thanks to Domenico Aquino and Alessandro Perin.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bush, N.A.O.; Chang, S.M.; Berger, M.S. Current and Future Strategies for Treatment of Glioma. Neurosurg. Rev. 2017, 40, 1–14. [Google Scholar] [CrossRef] [PubMed]
  2. D’Alessio, A.; Proietti, G.; Sica, G.; Scicchitano, B.M. Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue. Cancers 2019, 11, 469. [Google Scholar] [CrossRef] [PubMed]
  3. Cheung, E.Y.W.; Lee, K.H.Y.; Lau, W.T.L.; Lau, A.P.Y.; Wat, P.Y. Non-Coplanar VMAT Plans for Postoperative Primary Brain Tumour to Reduce Dose to Hippocampus, Temporal Lobe and Cochlea: A Planning Study. BJR|Open 2021, 3, 20210009. [Google Scholar] [CrossRef] [PubMed]
  4. Cheung, E.Y.W.; Ng, S.S.H.; Yung, S.H.Y.; Cheng, D.Y.T.; Chan, F.Y.C.; Cheng, J.K.Y. Multi-Planar VMAT Plans for High-Grade Glioma and Glioblastoma Targeting the Hypothalamic-Pituitary Axis Sparing. Life 2022, 12, 195. [Google Scholar] [CrossRef] [PubMed]
  5. Baba, A.; Câtoi, C. Tumor Cell Morphology. In Comparative Oncology; The Publishing House of the Romanian Academy: Bucharest, Romania, 2007; Volume 3. [Google Scholar]
  6. Hao, Y.; Zhang, L.; Qiao, S.; Bai, Y.; Cheng, R.; Xue, H.; Hou, Y.; Zhang, W.; Zhang, G. Breast Cancer Histopathological Images Classification Based on Deep Semantic Features and Gray Level Co-Occurrence Matrix. PLoS ONE 2022, 17, e0267955. [Google Scholar] [CrossRef] [PubMed]
  7. Kong, J.; Cooper, L.A.D.; Wang, F.; Gao, J.; Teodoro, G.; Scarpace, L.; Mikkelsen, T.; Schniederjan, M.J.; Moreno, C.S.; Saltz, J.H.; et al. Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates. PLoS ONE 2013, 8, e81049. [Google Scholar] [CrossRef] [PubMed]
  8. Madabhushi, A.; Lee, G. Image Analysis and Machine Learning in Digital Pathology: Challenges and Opportunities. Med. Image Anal. 2016, 33, 170–175. [Google Scholar] [CrossRef] [PubMed]
  9. Xu, J.; Janowczyk, A.; Chandran, S.; Madabhushi, A. A High-Throughput Active Contour Scheme for Segmentation of Histopathological Imagery. Med. Image Anal. 2011, 15, 851–862. [Google Scholar] [CrossRef]
  10. Davies, E.R. Texture Analysis. In Computer Vision; Elsevier: Amsterdam, The Netherlands, 2018; pp. 185–200. ISBN 978-0-12-809284-2. [Google Scholar]
  11. Galloway, M.M. Texture Analysis Using Gray Level Run Lengths. Comput. Graph. Image Process. 1975, 4, 172–179. [Google Scholar] [CrossRef]
  12. Hoffman, R.M.; Atallah, R.P.; Struble, R.D.; Badgett, R.G. Lung Cancer Screening with Low-Dose CT: A Meta-Analysis. J. Gen. Intern. Med. 2020, 35, 3015–3025. [Google Scholar] [CrossRef]
  13. Akazawa, M.; Hashimoto, K. Artificial Intelligence in Ovarian Cancer Diagnosis. Anticancer. Res. 2020, 40, 4795–4800. [Google Scholar] [CrossRef] [PubMed]
  14. Mahmood, H.; Shaban, M.; Indave, B.I.; Santos-Silva, A.R.; Rajpoot, N.; Khurram, S.A. Use of Artificial Intelligence in Diagnosis of Head and Neck Precancerous and Cancerous Lesions: A Systematic Review. Oral. Oncol. 2020, 110, 104885. [Google Scholar] [CrossRef] [PubMed]
  15. Zhang, Y.; Oikonomou, A.; Wong, A.; Haider, M.A.; Khalvati, F. Radiomics-Based Prognosis Analysis for Non-Small Cell Lung Cancer. Sci. Rep. 2017, 7, 46349. [Google Scholar] [CrossRef] [PubMed]
  16. Tang, F.; Chu, Y.-W.; Cheung, E.Y.W. Radiomics AI Prediction for Head and Neck Squamous Cell Carcinoma (HNSCC) Prognosis and Recurrence with Target Volume Approach. BJR|Open 2021, 3, 20200073. [Google Scholar] [CrossRef]
  17. Cheung, E.Y.W.; Chau, A.C.M.; Tang, F.H.; on behalf of the Alzheimer’s Disease Neuroimaging Initiative. Radiomics-Based Artificial Intelligence Differentiation of Neurodegenerative Diseases with Reference to the Volumetry. Life 2022, 12, 514. [Google Scholar] [CrossRef] [PubMed]
  18. Men, K.; Dai, J.; Li, Y. Automatic Segmentation of the Clinical Target Volume and Organs at Risk in the Planning CT for Rectal Cancer Using Deep Dilated Convolutional Neural Networks. Med. Phys. 2017, 44, 6377–6389. [Google Scholar] [CrossRef] [PubMed]
  19. Zhou, X. Automatic Segmentation of Multiple Organs on 3D CT Images by Using Deep Learning Approaches. Adv. Exp. Med. Biol. 2020, 1213, 135–147. [Google Scholar] [CrossRef]
  20. Reisert, M.; Sajonz, B.E.A.; Brugger, T.S.; Reinacher, P.C.; Russe, M.F.; Kellner, E.; Skibbe, H.; Coenen, V.A. Where Position Matters-Deep-Learning-Driven Normalization and Coregistration of Computed Tomography in the Postoperative Analysis of Deep Brain Stimulation. Neuromodulation 2023, 26, 302–309. [Google Scholar] [CrossRef]
  21. Pan, Z.; Zhang, R.; Shen, S.; Lin, Y.; Zhang, L.; Wang, X.; Ye, Q.; Wang, X.; Chen, J.; Zhao, Y.; et al. OWL: An Optimized and Independently Validated Machine Learning Prediction Model for Lung Cancer Screening Based on the UK Biobank, PLCO, and NLST Populations. eBioMedicine 2023, 88, 104443. [Google Scholar] [CrossRef]
  22. Mahmood, H.; Shaban, M.; Rajpoot, N.; Khurram, S.A. Artificial Intelligence-Based Methods in Head and Neck Cancer Diagnosis: An Overview. Br. J. Cancer 2021, 124, 1934–1940. [Google Scholar] [CrossRef]
  23. Hao, Y.; Qiao, S.; Zhang, L.; Xu, T.; Bai, Y.; Hu, H.; Zhang, W.; Zhang, G. Breast Cancer Histopathological Images Recognition Based on Low Dimensional Three-Channel Features. Front. Oncol. 2021, 11, 657560. [Google Scholar] [CrossRef] [PubMed]
  24. Belsare, A.D.; Mushrif, M.M.; Pangarkar, M.A.; Meshram, N. Classification of Breast Cancer Histopathology Images Using Texture Feature Analysis. In Proceedings of the TENCON 2015-2015 IEEE Region 10 Conference, Macao, China, 1–4 November 2015; pp. 1–5. [Google Scholar]
  25. Spanhol, F.A.; Oliveira, L.S.; Petitjean, C.; Heutte, L. A Dataset for Breast Cancer Histopathological Image Classification. IEEE Trans. Biomed. Eng. 2016, 63, 1455–1462. [Google Scholar] [CrossRef] [PubMed]
  26. He, S.; Xiao, B.; Wei, H.; Huang, S.; Chen, T. SVM Classifier of Cervical Histopathology Images Based on Texture and Morphological Features. Technol. Health Care 2022, 31, 69–80. [Google Scholar] [CrossRef] [PubMed]
  27. Clark, K.; Vendt, B.; Smith, K.; Freymann, J.; Kirby, J.; Koppel, P.; Moore, S.; Phillips, S.; Maffitt, D.; Pringle, M.; et al. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository. J. Digit. Imaging 2013, 26, 1045–1057. [Google Scholar] [CrossRef] [PubMed]
  28. Scarpace, L.; Mikkelsen, T.; Cha, S.; Rao, S.; Tekchandani, S.; Gutman, D.; Saltz, J.H.; Erickson, B.J.; Pedano, N.; Flanders, A.E.; et al. The Cancer Genome Atlas Glioblastoma Multiforme Collection (TCGA-GBM). Cancer Imaging Arch. Publ. Online 2016. [Google Scholar]
  29. Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 2007, 114, 97–109. [Google Scholar] [CrossRef] [PubMed]
  30. Wei, X. Gray Level Run Length Matrix Toolbox. Available online: https://www.mathworks.com/matlabcentral/fileexchange/17482-gray-level-run-length-matrix-toolbox (accessed on 24 October 2022).
  31. Tang, X. Texture Information in Run-Length Matrices. IEEE Trans. Image Process. 1998, 7, 1602–1609. [Google Scholar] [CrossRef] [PubMed]
  32. Soh, L.-K.; Tsatsoulis, C. Texture Analysis of SAR Sea Ice Imagery Using Gray Level Co-Occurrence Matrices. IEEE Trans. Geosci. Remote Sens. 1999, 37, 780–795. [Google Scholar] [CrossRef]
  33. Haralick, R.M.; Shanmugam, K.; Dinstein, I. Textural Features for Image Classification. IEEE Trans. Syst. Man Cybern. 1973, SMC-3, 610–621. [Google Scholar] [CrossRef]
  34. GLCM_Features4.m: Vectorized Version of GLCM_Features1.m [With Code Changes]. Available online: https://www.mathworks.com/matlabcentral/fileexchange/22354-glcm_features4-m-vectorized-version-of-glcm_features1-m-with-code-changes (accessed on 24 October 2022).
  35. Clausi, D.A. An Analysis of Co-Occurrence Texture Statistics as a Function of Grey Level Quantization. Can. J. Remote Sens. 2002, 28, 45–62. [Google Scholar] [CrossRef]
  36. Antoniou, G.; Deremer, D. (Eds.) Computing and Information Technologies: Exploring Emerging Technologies: Montclair State University, NJ, USA; World Scientific Pub. Co.: River Edge, NJ, USA, 2001; ISBN 978-981-02-4759-1. [Google Scholar]
  37. 3.1. Cross-Validation: Evaluating Estimator Performance. Available online: https://scikit-learn/stable/modules/cross_validation.html (accessed on 8 October 2022).
  38. Laws, K.I. Rapid Texture Identification; Wiener, T.F., Ed.; Optics & Photonics. Spie: San Diego, CA, USA, 1980; pp. 376–381. [Google Scholar]
  39. Willis, L.M. (Ed.) Professional Guide to Pathophysiology, 4th ed.; Wolters Kluwer: Philadelphia, PA, USA, 2019; ISBN 978-1-975107-69-7. [Google Scholar]
  40. Bhagat, P.K.; Choudhary, P.; Singh, K.M. A Comparative Study for Brain Tumor Detection in MRI Images Using Texture Features. In Sensors for Health Monitoring; Elsevier: Amsterdam, The Netherlands, 2019; pp. 259–287. ISBN 978-0-12-819361-7. [Google Scholar]
  41. Li, X.; Guindani, M.; Ng, C.S.; Hobbs, B.P. Spatial Bayesian Modeling of GLCM with Application to Malignant Lesion Characterization. J. Appl. Stat. 2018, 46, 230–246. [Google Scholar] [CrossRef]
  42. Shan, F.Y.; Zhao, D.; Tirado, C.A.; Fonkem, E.; Zhang, Y.; Feng, D.H.; Huang, J. Glioblastomas: Molecular Diagnosis and Pathology. In Glioblastoma-Current Evidence; Agrawal, A., Singh Kunwar, D., Eds.; IntechOpen: London, UK, 2023; ISBN 978-1-80356-128-8. [Google Scholar]
  43. Varuna Shree, N.; Kumar, T.N.R. Identification and Classification of Brain Tumor MRI Images with Feature Extraction Using DWT and Probabilistic Neural Network. Brain Inf. 2018, 5, 23–30. [Google Scholar] [CrossRef]
  44. Vapnik, V.N. Statistical Learning Theory. In Adaptive and Learning Systems for Signal Processing, Communications, and Control; Wiley: New York, NY, USA, 1998; ISBN 978-0-471-03003-4. [Google Scholar]
  45. Huang, M.-W.; Chen, C.-W.; Lin, W.-C.; Ke, S.-W.; Tsai, C.-F. SVM and SVM Ensembles in Breast Cancer Prediction. PLoS ONE 2017, 12, e0161501. [Google Scholar] [CrossRef]
  46. Galal, A.; Talal, M.; Moustafa, A. Applications of Machine Learning in Metabolomics: Disease Modeling and Classification. Front. Genet. 2022, 13, 1017340. [Google Scholar] [CrossRef]
Figure 1. The workflow of digitized image and pre-processing image.
Figure 1. The workflow of digitized image and pre-processing image.
Cancers 15 05063 g001
Figure 2. Detail study workflow.
Figure 2. Detail study workflow.
Cancers 15 05063 g002
Figure 3. A sample set of the H&E histology of normal brain tissue and GBM with histological characteristics.
Figure 3. A sample set of the H&E histology of normal brain tissue and GBM with histological characteristics.
Cancers 15 05063 g003
Figure 4. GLCM image features related to local intensity variation.
Figure 4. GLCM image features related to local intensity variation.
Cancers 15 05063 g004
Figure 5. GLCM image features related to entropy.
Figure 5. GLCM image features related to entropy.
Cancers 15 05063 g005
Figure 6. GLCM image features related to dissimilarity.
Figure 6. GLCM image features related to dissimilarity.
Cancers 15 05063 g006
Figure 7. GLCM image features related to energy and maximum probability.
Figure 7. GLCM image features related to energy and maximum probability.
Cancers 15 05063 g007
Figure 8. GLCM image features related to homogeneity.
Figure 8. GLCM image features related to homogeneity.
Cancers 15 05063 g008aCancers 15 05063 g008b
Figure 9. GLRLM image features.
Figure 9. GLRLM image features.
Cancers 15 05063 g009
Figure 10. Model building: ROC curve analysis between the five models.
Figure 10. Model building: ROC curve analysis between the five models.
Cancers 15 05063 g010
Figure 11. ROC curves for deployment of AI models.
Figure 11. ROC curves for deployment of AI models.
Cancers 15 05063 g011
Table 1. Details of study dataset.
Table 1. Details of study dataset.
Cohort 1: for Model Building
(TCGA–GBM)
Cohort 2: for Model Deployment
(Local Hospital)
No of ParticipantsNo of ImagesNo of ParticipantsNo of Images
GBM262150060702
Normal40150020670
Table 2. GLCM and GLRLM image features.
Table 2. GLCM and GLRLM image features.
Gray Level Co-Occurrence Matrix (GLCM)Gray Level Run Length Matrix (GLRLM) [30,31]
Autocorrelation [32]Maximum Probability [32]Short Run Emphasis
Contrast [32,33]Sum of square [33]Long Run Emphasis
Correlation 1 [34]Sum average [33]Gray Level Non-uniformity
Correlation 2 [32,33]Sum variance [33]Run Length Non-uniformity
Cluster prominence [32]Sum entropy [33]Run Percentage
Cluster Shade [32]Difference variance [33]Low Gray-level Run Emphasis
Dissimilarity [32]Difference entropy [33]High Gray-level Run Emphasis
Energy [32,33]Information measure of
correlation 1 [33]
Short Run Low Gray-level
Run Emphasis
Entropy [32]Information measure of
correlation 2 [33]
Short Run High Gray-level
Run Emphasis
Homogeneity 1 [34]Inverse Difference
normalized [35]
Long Run Low Gray-level
Run Emphasis
Homogeneity 2 [32]Inverse Difference
moment normalized [35]
Long Rg equations to obtain each features were listed in the . es were y. Rrun High Gray-level
Run Emphasis
Table 3. Image distribution of the study for model development (Part 1) and model deployment (Part 2).
Table 3. Image distribution of the study for model development (Part 1) and model deployment (Part 2).
Part 1
Model
development
GBM group (n = 1500)Normal Group (n = 1500)
GroupTrainingValidationTestingTrainingValidationTesting
Percentage70%15%15%70%15%15%
Sample size10502252251050225225
Part 2
Model
deployment
GBM group (n = 702)Normal Group (n = 670)
GroupTrainingValidationTestingTrainingValidationTesting
Percentage70%15%15%70%15%15%
Sample size492105105470100100
Table 4. Demographics of the GBM of the TCGA and the local hospital dataset.
Table 4. Demographics of the GBM of the TCGA and the local hospital dataset.
Part 1
For Model Development
Part 2
For Model Deployment
GBMNormalGBMNormal
No of Participants262406020
Age Range
Mean ±SD
Sex (M:F)
14–86
58.96 ± 13.95
159:101
NIL33–75
61 ± 11.06
42:18
NIL
Table 5. Overall accuracy, sensitivity, and specificity for GBM diagnosis using H&E image features.
Table 5. Overall accuracy, sensitivity, and specificity for GBM diagnosis using H&E image features.
AlgorithmOverall
Accuracy
SensitivitySpecificityArea under
the ROC Curve
PrecisionRecallF1 Score
Decision Tree (DT)100%100%100%1100%100%1
Extreme Boost (EB)100%100%100%1100%100%1
Random Forest (RF)100%100%100%1100%100%1
Support Vector Machine (SVM)100%100%100%1100%100%1
Linear Model (LM)100%100%100%1100%100%1
Table 6. Overall accuracy, sensitivity, and specificity in model deployment.
Table 6. Overall accuracy, sensitivity, and specificity in model deployment.
AlgorithmOverall AccuracySensitivitySpecificityArea under
the ROC Curve
PrecisionRecallF1 Score
DT-Model59.4%18.82%10.535717.2%100%29.3%
EB-Model59.4%18.8210.593617.2%100%29.3%
RF-Model60.3%21.06%10.628320.8%100%34.4%
SVM-Model93.5%86.95%99.73%0.990882.9%99.7%90.5%
LM-Model55.0%11.80%10.53980%100%0%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cheung, E.Y.W.; Wu, R.W.K.; Li, A.S.M.; Chu, E.S.M. AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis. Cancers 2023, 15, 5063. https://doi.org/10.3390/cancers15205063

AMA Style

Cheung EYW, Wu RWK, Li ASM, Chu ESM. AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis. Cancers. 2023; 15(20):5063. https://doi.org/10.3390/cancers15205063

Chicago/Turabian Style

Cheung, Eva Y. W., Ricky W. K. Wu, Albert S. M. Li, and Ellie S. M. Chu. 2023. "AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis" Cancers 15, no. 20: 5063. https://doi.org/10.3390/cancers15205063

APA Style

Cheung, E. Y. W., Wu, R. W. K., Li, A. S. M., & Chu, E. S. M. (2023). AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis. Cancers, 15(20), 5063. https://doi.org/10.3390/cancers15205063

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop